Clinical Trial Update: In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial registry entry describes an IHNI-based boron neutron capture therapy approach being studied for malignant melanoma in Phase 1/Phase 2, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Melanoma, Boron Neutron Capture Therapy | Phase 1, Phase 2 | Status: UNKNOWN